Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
PUT
Alliant Energy
LNT
$18.3B
| $6.08M | ﹤0.01% |
103,800
+88,500
| +578% | +$5.34M |
|
3352
Direxion Daily Financial Bull 3x ETF
FAS
$2.49B
| $6.08M | ﹤0.01% |
+96,341
| New | +$8.2M |
|
3353
CALL
Cracker Barrel
CBRL
$1.29B
| $6.08M | ﹤0.01% |
72,800
-63,100
| -46% | -$6.56M |
|
3354
Revolve Group
RVLV
$1.68B
| $6.08M | ﹤0.01% |
234,540
-360,840
| -61% | -$13.3M |
|
3355
Rockwell Automation
ROK
$49.9B
| $6.07M | ﹤0.01% |
30,443
-83,885
| -73% | -$18.9M |
|
3356
PUT
Innovative Industrial Properties
IIPR
$1.62B
| $6.07M | ﹤0.01% |
55,200
-98,100
| -64% | -$13.9M |
|
3357
PUT
Conagra Brands
CAG
$7.5B
| $6.06M | ﹤0.01% |
177,000
+24,700
| +16% | +$841K |
|
|
ELP
3358
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $6.05M | ﹤0.01% |
1,189,990
+787,950
| +196% | +$4.5M |
|
3359
CALL
New York Times
NYT
$10.4B
| $6.05M | ﹤0.01% |
217,000
+100,900
| +87% | +$3.64M |
|
3360
PUT
FIVE9
FIVN
$2.47B
| $6.05M | ﹤0.01% |
66,400
-11,100
| -14% | -$1.12M |
|
3361
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.93B
| $6.05M | ﹤0.01% |
229,685
-412,400
| -64% | -$11M |
|
3362
CALL
VICI Properties
VICI
$29B
| $6.05M | ﹤0.01% |
203,044
+44,744
| +28% | +$1.32M |
|
3363
CALL
iShares Russell 2000 Growth ETF
IWO
$15.2B
| $6.04M | ﹤0.01% |
29,300
-11,600
| -28% | -$2.59M |
|
3364
PUT
Celldex Therapeutics
CLDX
$3.29B
| $6.04M | ﹤0.01% |
224,200
+125,700
| +128% | +$3.65M |
|
3365
CALL
Tenet Healthcare
THC
$21.6B
| $6.04M | ﹤0.01% |
115,000
-37,800
| -25% | -$2.63M |
|
|
VIRX
3366
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $6.04M | ﹤0.01% |
1,556,222
-8,792
| -0.6% | -$25K |
|
3367
Under Armour
UAA
$2.3B
| $6.04M | ﹤0.01% |
724,562
-3,816,441
| -84% | -$46.8M |
|
3368
CALL
JPMorgan Equity Premium Income ETF
JEPI
$46.3B
| $6.03M | ﹤0.01% |
108,800
+27,500
| +34% | +$1.59M |
|
3369
Olema Pharmaceuticals
OLMA
$930M
| $6.03M | ﹤0.01% |
1,481,215
+219,550
| +17% | +$696K |
|
|
TRQ
3370
CALL
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $6.03M | ﹤0.01% |
225,100
-35,000
| -13% | -$991K |
|
|
BNY
3371
CALL
Bank of New York Mellon
BNY
$111B
| $6.03M | ﹤0.01% |
144,500
-116,800
| -45% | -$5.2M |
|
3372
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.25B
| $6.02M | ﹤0.01% |
160,943
+78,562
| +95% | +$3.2M |
|
|
SPR
3373
PUT
DELISTED
Spirit AeroSystems
SPR
| $6.02M | ﹤0.01% |
205,500
-148,200
| -42% | -$5.31M |
|
3374
Titan International
TWI
$445M
| $6.02M | ﹤0.01% |
398,751
+220,065
| +123% | +$3.55M |
|
3375
PUT
Opendoor
OPEN
$3.53B
| $6.02M | ﹤0.01% |
1,320,393
-125,137
| -9% | -$825K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.